Trial Profile
A Phase IIb Study Evaluating the Safety and Efficacy of Multiple Doses of CNS 7056 Compared to Midazolam in Patients Undergoing Colonoscopy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2019
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary) ; Midazolam
- Indications Sedation
- Focus Therapeutic Use
- Sponsors PAION
- 19 Jun 2016 Results published in a PAION media release.
- 12 Nov 2014 New trial record
- 01 Oct 2014 Results published in PAION media release, and presented at the American College of Gastroenterology Annual Scientific Meeting (ACG) in October 2014, according the media release.